Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |